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The Treatment of Menorrhagia with 





The purpose of this work was the development and application of a new herbal ointment 
and pessaries for the topical treatment of menorrhagia using macerates and essential oils of 
medicinal plants as active ingredients. Fifty subjects with proven menorrhagia ranging from 
32 to 54 years were divided into two groups (each had 25 participants) of similar age, health 
status and lifestyle. The first group used 2 g of ointment every eight hours while the second 
group used pessaries instead. The results were obtained at baseline and following the third 
menstrual cycle. In both groups a significant decrease was observed for all the symptoms 
(p<0.05). Significantly better results were obtained in the case of the ointment compared to 
the pessaries as expected due to the higher percentage of the active ingredients. The average 
duration of bleeding was reduced from 7.4 to 4.7 days in the case of the ointment and from 
7.3 to 5.1 days in the group who used pessaries. The average number of painkillers is reduced 
from 22.1 to 10.6 and from 22.9 to 13.1 in the group using the ointment and pessaries, 
respectively. Decrease in other symptoms ranged from 71.4% up to 88.2% in the group 
using the ointment and from 57.3% to 73.7% in the case of pessaries usage. The obtained 
results could be correlated with the use of active ingredients with proven haemostatic, 
vasoconstrictor, astringent and spasmolytic activity. 
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Introduction
Menorrhagia is the most common form of abnormal uterine 
bleeding characterized by prolonged and abundant menstrual 
bleeding whereby over 80 mL of blood per cycle is lost (Oehler and 
Rees, 2003; Livdans-Forret et al., 2007; Beebeejaun and Varma, 
2013). The signs and the symptoms of menorrhagia may include: 
changing the sanitary pad or tampon every hour for several 
hours, using twice as many pads or tampons during the menstrual 
period, waking during the night to change the pad or the tampon, 
bleeding for longer than a week, blood clots that appear longer 
than a day, the inability to perform normal daily activities due 
to severe bleeding, anemia symptoms, such as fatigue or lack of 
breath.
According to Beebeejaun and Varma (2013) the most 
common causes of menorrhagia are: hormonal imbalance, 
dysfunction of the ovaries, uterine fibroids, polyps of the uterus, 
intrauterine device for birth control, pregnancy complications 
due to miscarriage, implantation of a fertilized egg in the fallopian 
tube instead of the uterus, cancer (uterine, ovarian, cervical), 
hereditary bleeding disorders (blood clotting disorders), drugs, 
other medical conditions (pelvic inflammatory diseases, thyroid 
problems, endometriosis, liver and kidney disease). The standard 
treatment of menorrhagia may include drug therapy such as: 
iron supplements in the case of anemia, non-steroidal anti-
inflammatory drugs, oral contraceptives and progesterone tablets. 
In the cases of un-successful drug therapy, there is an option of 
surgical treatment like dilatation and curettage, embolization of 
blood vessels of the uterus (in the case of presence of myomas), 
myomectomy, endometrial ablation, hysterectomy (Beebeejaun 
and Varma, 2013; Bradley and Gueye, 2016). Herbal preparations 
with either astringent and/or uterotonic activity have also been 
used to combat menorrhagia (Livdans-Forret et al., 2007).
The purpose of this work was the formulation and application 
of the herbal preparations in the form of ointment and pessaries 
for the treatment of menorrhagia in reproductive age females.
Materials and methods
Patients
Among 112 females reported to the Center due to heavy 
menstrual bleeding in 50 of them menorrhagia was confirmed. 
The subjects were randomly divided into two groups (each had 
25 participants) of similar age, health status and lifestyle. All the 
patients signed written consent for the participation in the study.
Preparation of the macerate
The macerate was prepared from dried plant material of 15% 
of Capsella bursa-pastoris (L.) Medik., 15% of Alchemilla vulgaris 
L., 15% of Achillea millefolium L., 15% of Plantago major L., 10% of 
Polygonum aviculare L., 10% of Salvia officinalis L., 5% of Quercus 
robur L., 5% Olea europaea L., 5% Calendula officinalis L., 5% 
Matricaria chamomilla L. (Suban, Strmec Samoborski, Croatia) 
and extra virgin olive oil. Solid:liquid ratio was 1:5. Maceration 
time was 21 days at 50°C. The macerate was separated from the 
solid part by filtration.
Preparation of the ointment
For the preparation of the ointment 80% of the macerate, 5% 
of glycerol (Kemig, Zagreb, Croatia), 4.3% of honey (Kemig) and 
10% of Cera alba (Kemig) was heated to 60°C for ten minutes, 
mixed and then cooled to the room temperature. The mixture 
was homogenized and supplemented with 0.2% of Melaleuca 
alternifolia (Maiden & Betche) Cheel oil, 0.1 % Syzygium 
aromaticum (L.) Merr. & L.M.Perry oil, 0.1% of Cymbopogon 
martini (Roxb.) W.Watson oil, 0.1% Cinnamomum camphora (L.) 
J.Presl ct. cineol oil, 0.1% of Thymus vulgaris L. ct. timol oil and 
0.1% of Origanum compactum Benth. oil, homogenized once again 
and packed into 50 mL tubes (Oreščanin and Findri Guštek., 2016; 
2017). All essential oils were of pharmaceutical grade produced by 
Pranarom International, Ghislenghien, Belgium. 
Preparation of the pessaries
For the preparation of the pessaries (Oreščanin et al., 2015) 
40% of the macerate, 4.3% of Cera alba (Kemig) and 54.6% of 
Witepsol E75 (Kemig) were heated until 60°C, mixed slowly for 
10 minutes and allowed to cool to 30°C. Pharmaceutical grade 
essential oils (Pranarom International) of M. alternifolia (0.2%), 
T. vulgaris (0.2%), E. caryophyllata (0.2%), C. camphora ct. cineol 
(0.1%), C. martini (0.1%) and O. compactum (0.1%) were added 
into the mixture, mixed thoroughly and packed into high quality 
plastic strips (Meyer GMBH, Ober-Mörlen, Germany) containing 
ten single cells each of 3 g. 
The treatment 
Both groups were treated during three consecutive menstrual 
cycles. The first group applied 2 g of the ointment deep into vagina 
every eight hours while the second group used pessaries (one 
pessary every eight hours). The results were obtained at baseline 
and following the third menstrual cycle. The improvement was 
monitored by the reduction in the number of spent sanitary pads 
or tampons, waking during the night in order to change the pads 
or tampons, the duration of bleeding, appearance of the blood 
clots and the number of painkillers consumed. 
Statistical analysis
The difference between the values before and following 
the treatment as well as between two herbal preparations was 
assessed by t-test using STATISTICA 12.0 software package. The 
significance level was set to p<0.05.
Results and discussion
The age of the ointment treated women ranged from 32 to 54 
years (47.2±4.9) and in the pessaries treated group women were 
from 33 to 52 years old (47.9±4.3). The average number of spent 
sanitary pads or tampons before the treatment was 38±7.7 (29-
47) in the ointment and 37±7.4 (30-44) in the pessaries treatment 
group. The average changing during the night was 7±2.2 (5-9) 
and 6±2.1 (5-8) times in the ointment and pessaries treatment 
group, respectively. The average duration of bleeding lasted 
7.4±2.3 (6-9) and 7.3±2.1 (6-9) day, respectively. The blood clots 
appeared during the first three days of the period. The average 
number of consumed painkillers was 22.1±4.4 and 22.9±3.9 in the 
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ointment and the pessaries treatment group, respectively. Besides, 
unpleasant odor was present in all participants regardless of the 
group. Furthermore, 20 participants from the ointment group 
and 18 participants from the pessaries group suffered from the 
symptoms like burning, redness, irritation that occurred during 
or in the end of the cycle. All the parameters showed statistically 
significant decrease in both groups following the treatment during 
three consecutive cycles. The average number of spent sanitary 
pads or tampons decreased to 10.9±2.7 in the ointment and to 
14.9±3.9 in the pessaries treatment group and changing during 
the night to 0.8±0.2 and 1.6±0.3 in the ointment and pessaries 
treatment group, respectively. The average duration of bleeding 
was reduced to 4.7±0.7 days in the case of the ointment and to 
5.1±0.9 days in the group who used pessaries, while the number of 
the painkillers was reduced to 10.6±2.2 and 13.1±3.4, respectively. 
The blood clots were reduced for 79.6% and 57.3% in the ointment 
and pessaries treatment group, respectively. When comparing the 
percentages of the reduction of each parameter between two groups 
significantly higher reduction of all parameters was obtained in 
the case of the ointment use (Table 1). This was expected since the 
ointment contains 80% of the macerate of the plants with strong 
haemostatic, astringent, vasoconstrictor and spasmolytic activity, 
while the content of those plant macerates in the pessaries was 
only 40%. Moreover, unpleasant odor during the period was also 
reduced or disappeared completely in both groups. The symptoms 
like burning, redness, irritation that occurred in the most of the 
patients after menstruation disappeared completely upon the 
treatment with ointment and pessaries. 
Obtained results could be correlated with the presence of herbal 
ingredients with proven haemostatic activity such as C. bursa-
pastoris (EMA, 2010), A. millefolium (Rauchensteiner et al., 2004), 
P. major (Samuelsen, 2000), A. vulgaris (Shrivastava et al., 2007) 
and P. aviculare C. bursa-pastoris, A. millefolium and A. vulgaris 
also acting as vasoconstrictor and Q. robur, S. officinalis, A. vulgaris 
and O. europaea as an astringent (Oreščanin and Findri Guštek, 
2016) all of which resulted in reduced bleeding. Furthermore, C. 
officinalis, Salvia officinalis L., Achilea millefolium L. and Alchemilla 
vulgaris L. have also spasmolytic effect and contributed to the 
reduction of spasticity and pain (Oreščanin and Findri Guštek., 
2016). All these herbal ingredients including all essential oils used 
due to their powerful antimicrobial effect (Oreščanin et al., 2015) 
prevented the development of infection with anaerobic bacteria 
in particular, which is very common during and after the period. 
Table 1. Mean values and standard deviations expressed as the percentages of the reduction of menorrhagic symptoms following the treatment 
with herbal ointment or pessaries and t-test scores between two groups of the subjects.
Parameter Ointment Pessaries P
Reduction in the number of spent sanitary pads or tampons 71.4±5.9 59.7±4.8 <0.0001*
Reduction of waking during the night 88.2±7.3 73.7±6.2 <0.0001*
Reduction of the duration of bleeding 37.1±4.4 29.5±3.6 <0.0001*
Reduction of the blood clots 79.6±6.1 57.3±5.7 <0.0001*
Reduction in the number of painkillers consumed 51.7±4.5 42.6±3.9 <0.0001*
*significant at P< 0.05
The deodorant effect of essential oils prevented the development 
of unpleasant odor.
Conclusion
Conducted preliminary research has shown that both herbal 
products have a significant positive effect on alleviating the 
symptoms of menorrhagia since all the observed parameters 
in both groups of the patients were significantly lower after the 
treatment. Such results are attributable to the combination of 
the herbal ingredients with proven haemostatic, astringent, 
vasoconstrictor, spasmolytic and anti-microbial properties. 
Significantly better results were obtained in the group using the 
ointment compared to the group using the pessaries, which was 
expected since the ointment contains two times more active 
ingredients compared to the pessaries.
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